CPT® Code 82523

The CPT® Code 82523 refers to the measurement of collagen cross links using any method, specifically focusing on the peptide fragments known as N-Telopeptide and C-Telopeptide. These fragments are derived from the protein matrix of bone and serve as important biomarkers in assessing bone metabolism. The N-Telopeptide can be detected in both serum and urine, making it a versatile marker for evaluating bone resorption. In clinical practice, a baseline measurement of N-Telopeptide is typically obtained before initiating treatment with bisphosphonates or hormone replacement therapy, particularly in postmenopausal women or individuals diagnosed with osteopenia. This initial assessment is crucial for establishing a reference point for future evaluations. Following the initiation of therapy, the N-Telopeptide levels are monitored at intervals of three months and six months to determine the effectiveness of the treatment. Similarly, C-Telopeptide, which is exclusively measured in serum, is utilized to monitor the therapeutic response to bisphosphonates or hormone replacement therapy in the same patient populations. The collection of samples for these tests involves venipuncture for blood samples, which must be reported separately, while urine samples can be collected randomly or over a 24-hour period. The testing methodologies employed include quantitative chemiluminescent immunoassay for urine N-Telopeptide, quantitative enzyme-linked immunosorbent assay for serum N-Telopeptide, and quantitative electrochemiluminescent immunoassay for serum C-Telopeptide. These tests provide valuable insights into bone health and the effectiveness of ongoing treatment regimens.